Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Omalizumab (Atc Code: R03Dx05).
Deadline - Sep 27, 2026
GT reference number - 113625844
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 113625844
Document Type - Tender Notices
Description - Description: Completion of a non-exclusive discount contract according to Section 130a (8) SGB V to medicinal products with the active ingredient omalizumab (ATC code: R03DX05) within the period from 01.12.2024 to 30.11.2026 with any option of comple tion of the contract during the running time ("open house model").local title:: Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Omalizumab (ATC-Code: R03DX05).Contract Type: : Supplylocal description: : Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Omalizumab (ATC-Code: R03DX05) innerhalb des Zeitraumes vom 01.12.2024 bis
Gt Ref Id - 113625844
Deadline - Sep 27, 2026
Similar Tenders :
Summary:
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database